USPTO serial 98612625
ELI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 28, 2026
- Examiner
- GERMICK JR., EDWARD JOSEPH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ELI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Montréal, QC, CA
Montréal, QC, CA
Montréal, QC, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rajesh Fotedar
Rajesh Fotedar Cognition IP P.C.50 California St., 1500San Francisco, CA 94111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software application for analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable mobile software application for analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for presentation of data from analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable mobile software application for presentation of data from analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for analysis of hormone levels, namely, progesterone, cortisol, and estradiol detected in personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for presentation of data from analysis of hormone levels, namely, progesterone, cortisol, and estradiol detected in personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable mobile software application for presentation of data from analysis of hormone levels, namely, progesterone, cortisol, and estradiol detected in personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for analysis of a collected sample of saliva; downloadable mobile software application for analysis of a collected sample of saliva; downloadable software application for analysis of a collected sample of bodily fluids; downloadable mobile software application for analysis of a collected sample of bodily fluid; downloadable software application for analysis of personally collected bodily fluids, bodily fluids collected in a non-clinical setting, and bodily fluids collected at home; downloadable mobile software application for analysis of personally collected bodily fluids, bodily fluids collected in a non-clinical setting, and bodily fluids collected at home; downloadable software application for analysis of hormone levels detected in a collected sample of saliva; downloadable mobile software application for analysis of hormone levels detected in a collected sample of saliva; downloadable software application for analysis of hormone levels detected in a collected sample of bodily fluid; downloadable mobile software application for analysis of hormone levels detected in a collected sample of bodily fluid; downloadable software application for presentation of data from analysis of hormone levels in a collected sample of saliva; downloadable mobile software application for presentation of data from analysis of hormone levels in a collected sample of saliva; downloadable software application for presentation of data from analysis of hormone levels in a collected sample of bodily fluid; downloadable mobile software application for presentation of data from analysis of hormone levels in a collected sample of bodily fluid; wireless communication devices for wireless transmission of medical data and information, namely, devices for transmitting data from a cartridge with a sample of saliva. | ACTIVE | Feb 18, 2025 |
| 010 | saliva collection devices for medical purposes; cartridges for collection of saliva samples for use with medical devices; cartridges for personal collection of saliva, collection of saliva in a non-clinical setting, and at-home collection of saliva, all for use with medical devices; bodily fluid sample collection devices for medical purposes; cartridge for collection of bodily fluid samples for use with medical devices; cartridge for personal collection of bodily fluids, collection of bodily fluids in a non-clinical setting, and at-home collection of bodily fluids, all for use with medical devices | ACTIVE | Jan 8, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 7, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 10, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 25, 2026 | IUAF | USE AMENDMENT FILED | — |
| Feb 25, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 25, 2026 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Feb 25, 2026 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Feb 25, 2026 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 25, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Feb 2, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 2, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 1, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 6, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 6, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 30, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 4, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 31, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 31, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 31, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 31, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 21, 2024 | NWAP | NEW APPLICATION ENTERED | — |